Featured
Last news
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
LONDON, UK / ACCESS Newswire / February 20, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that its exclusive, out-licensed patent application for "Variants of SIRT6 for Use in Preventing and/or Treating Age-Related Diseases" has successfully progressed through the Supplementary European Search Report without further questions from the European Patent Office (EPO).
Could 'terrorist' designation lead to US strikes on drug cartels?
US President Donald Trump's decision to designate eight Latin American drug trafficking groups as "terrorist" organizations has raised speculation about possible military action on foreign soil.
No immediate ruling on 'unusual' move to drop New York mayor corruption case
A US federal judge peppered a top member of Donald Trump's Justice Department with questions Wednesday during a hearing over the office's extraordinary move to drop corruption charges against New York Mayor Eric Adams.
Yoon to become South Korea's first sitting president to go on criminal trial
Ousted South Korean leader Yoon Suk Yeol will become the country's first sitting head of state to stand trial in a criminal case as hearings open Thursday on his bid to impose martial law.
Latin America's 'terrorist' cartels in Trump's sights
From Mexico's most ruthless drug cartels to Central America's most notorious street gang, these are the eight drug trafficking groups being designated terrorist organizations by US President Donald Trump's administration:
Pope's tests show improvement, Italy PM visits
Pope Francis's blood tests show a "slight improvement" as he receives hospital treatment for pneumonia, the Vatican said Wednesday, while Italy's prime minister found the 88-year-old joking "as always".
Syrian Jews say held first group prayer in decades in Damascus synagogue
Syria's tiny Jewish community said they held their first group prayer in decades Wednesday, in a synagogue in Damascus's Old City, expressing joy at the long-awaited return to public worship.
Call for 'maximum' sentence for Bosnian Serb leader
Prosecutors demanded a near five-year jail sentence Wednesday for Bosnian Serb leader Milorad Dodik for defying the envoy who oversees the peace accords that ended the country's bloody 1990s war.
UK accusers of influencer Tate urge US to stay away from case
Four British women who have accused notorious influencer Andrew Tate of rape said Wednesday they were "concerned" by reports the US government was petitioning Romania to ease his travel restrictions.
Teamwork key to smashing European doping networks: WADA investigations chief
A collaboration between the Serbian anti-doping agency and law enforcement operatives who seized 3,000 kilogrammes of performance-enhancing drugs and broke up an organised crime gang last year is "the future in the fight against doping", WADA's Director of Intelligence and Investigations Gunter Younger has told AFP.
Pope 'breathing on his own' despite pneumonia: Vatican source
Pope Francis's heart is holding up very well despite his pneumonia, a Vatican source said Wednesday, amid growing concerns over the hospitalised 88-year-old's condition.
UK govt cracks down on online knife sales
A new law introduced after a spate of high-profile knife crimes will make it harder for young people to purchase knives online, the UK government announced Wednesday.
Pope, suffering from pneumonia, had 'peaceful night'
Pope Francis, who has been diagnosed with pneumonia in both lungs, passed a "peaceful night", the Vatican said Wednesday, amid growing concerns over the 88-year-old's condition.
Peru's 12-Angle Stone vandalized, causing 'irreversible damage'
An allegedly intoxicated man vandalized a 500-year-old archaeological artifact known as the 12-Angle Stone in Peru, authorities said Tuesday.
UN watchdog chief visits Fukushima as Japan returns to nuclear power
The UN nuclear watchdog chief visited Japan's stricken Fukushima plant on Wednesday, the day after Tokyo approved an energy plan that marks a return to nuclear power to meet growing demand for AI.
Top South Korean judge faces disinformation deluge as Yoon impeachment looms
Bogus child pornography claims, fabricated support for communism and fake posts showing Elon Musk calling for his removal -- a deluge of disinformation is targeting a top judge in suspended South Korean President Yoon Suk Yeol's impeachment trial.
Rapper A$AP Rocky found not guilty in assault trial
Rapper A$AP Rocky was found not guilty of two counts of felony assault at the conclusion of a trial in Los Angeles on Tuesday.
Havertys Announces First Quarter 2025 Cash Dividend
ATLANTA, GA / ACCESS Newswire / February 19, 2025 / HAVERTYS (NYSE:HVT and HVT.A) announced today that its board of directors declared a cash dividend to be paid on the outstanding shares of the two classes of $1 par value common stock of the company at a rate of $0.32 per share on the common stock and $0.30 per share on the Class A common stock. The dividend is payable on March 21, 2025, to stockholders of record at the close of business on March 6, 2025. Havertys has paid a cash dividend in each year since 1935.
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Seventh consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP)1, delivering results at the high-end and/or exceeding 2024 guidanceFourth Quarter Consolidated Revenues of $2.56 billion, up 6% on a Reported basis and up 9% on an Organic (non-GAAP)1 basis over the prior year periodFull-Year Consolidated Revenues of $9.63 billion, up 10% on a Reported basis and 8% on an Organic (non-GAAP)1 basis, with growth in all segmentsGAAP Net Income Attributable to Bausch Health Companies Inc. of $93 million for the quarter and GAAP Net Loss of $46 million for the yearConsolidated Adjusted EBITDA Attributable to Bausch Health Companies Inc. (non-GAAP)1 of $935 million for the quarter, up 8%, and $3.31 billion for the year, up 10%
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
LONDON, UK / ACCESS Newswire / February 19, 2025 / NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition Corp. stockholders on January 31, 2025, and it closed on February 17, 2025. Beginning on February 20, 2025, Aspire Biopharma shares of common stock and warrants will begin to trade on the Nasdaq Global Market and Nasdaq Capital Market (collectively, "Nasdaq"), respectively, under the ticker symbols "ASBP" and "ASBPW," respectively.
Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)
This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and microvillus inclusion disease (MVID) in the US, EU, and/or Middle East/North Africa regionsAvailability of first IIT proof-of-concept results potentially in H1 2025Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both SBS-IF and MVID
Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
On-demand video webcast now available here
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
On-demand video webcast now available here
Dolphin Expands Loyalty Program With Exclusive New Perks
New Perks Include 2 Tickets To See Any Live Concert at The Capitol Theatre in New York plus Saysh Sneaker Discount and more
CNS Pharmaceuticals Announces Reverse Stock Split
HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") on a split adjusted basis under the trading symbol "CNSP", but will trade under the following new CUSIP number: 18978H409. The reverse stock split is primarily intended to increase the Company's per share trading price and bring the Company into compliance with the Nasdaq's listing requirement regarding minimum share price.
Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform
Ambient AI technology can help reduce clinician burnout and enhance patient care
CBMJ Reduces Debt 44% by Restructuring AMP News Note - Additional Reductions to Follow Over Next Six Months
ATLANTA, GA / ACCESS Newswire / February 19, 2025 / Conservative Broadcast Media & Journalism (OTC PINK:CBMJ) announced that it has reduced its overall debt by approximately 44%. This was accomplished by restructuring the $1.89M balance owed under a $2.0M note from the original purchase by AMP News, Inc., a CBMJ wholly owned subsidiary, of the independent broadcast media, news and entertainment business assets owned by American Media Periscope LLC.
Interactive Strength Inc. (Nasdaq:TRNR) Increases 2025 Expectations to More Than $50M in Pro Forma Revenues
New Investor Presentation on Growth Strategy and Expected Sportstech Acquisition
CBDL Launches New Mushroom Supplement Drink & Smoothie Bar
The functional mushroom industry is exploding, set to surpass $69 billion by 2028, and CBDL is seizing the moment-unlocking a massive revenue opportunity with its latest game-changing expansion.
NanoViricides, Inc. Has Filed its Quarterly Report
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu
Kiffik Announces Global Partnership With Duracell(R) Batteries To Power New, Innovative Health Monitoring Technology
Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various biomarkers in the body.